Skip to main content
Caplight Logo









Valorize Bioscience

Valorize Bioscience

Private
Chicago, IllinoisFrontier & Industrial Techhttps://www.valorizebioscience.com/

Last Round

Grant

Nov 20, 2024

Total Funding Raised

$55,000

Company Overview

Valorize Bioscience is a food technology company that has developed patented processing technology to improve the sensory characteristics of insect proteins for use in human and pet food.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Circular Economy, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

insect proteindownstream processingfood techalternative proteintechnology licensinginsect ingredientsingredient processingpet food ingredientshuman food ingredientsprotein solubilityinsect farmingfunctional ingredientsB2B ingredientsinsect mealcircular economy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valorize Bioscience Comparables

Compare Valorize Bioscience with similar companies based on industry and business-model similarity.

Valorize Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
All Things Bugs LLC
76%
The Bland Company
61%
GEA Group
59%

Valorize Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2024
AcceleratorMay 11, 2022
Pre SeedApr 1, 2022

Valorize Bioscience Investors

Notable investors and investment history

Valorize Bioscience investors
InvestorRounds
NC IDEAGrant
Charlotte Angel FundPre Seed
Stone Mountain VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors grew 154% MoM, reaching 1.4K.

  • Nov 20, 2024

    $50K grant received from NC IDEA.

Valorize Bioscience Filings

Explore SEC and related filing metadata, where available.

Valorize Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Valorize Bioscience's valuation, stock price, and market status.

Is Valorize Bioscience a public or private company?

Valorize Bioscience is a private company.

What is the current stock price of Valorize Bioscience?

Valorize Bioscience is a private company with no public stock price. No recent secondary market data is available.

How much is Valorize Bioscience worth (valuation)?

Valuation information for Valorize Bioscience is not publicly available.

Can I buy Valorize Bioscience stock?

Valorize Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Valorize Bioscience's last funding round?

Funding round information for Valorize Bioscience is not publicly available.

Who are the main investors in Valorize Bioscience?

Investor information for Valorize Bioscience is not publicly disclosed.

Will Valorize Bioscience IPO soon?

No public IPO plans have been announced for Valorize Bioscience.

How can I track Valorize Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Valorize Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range3
Year Founded2018
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?